Dr. Caress is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
131 Miller St
Winston Salem, NC 27103Phone+1 336-716-2309Fax+1 336-713-8588
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1994 - 1996
- Duke University HospitalResidency, Neurology, 1991 - 1994
- George Washington UniversityInternship, Internal Medicine, 1990 - 1991
- George Washington University School of Medicine and Health SciencesClass of 1990
Certifications & Licensure
- NC State Medical License 1996 - 2025
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Clinical Neurophysiology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
Clinical Trials
- Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2013 Aug 01
- A Trial of Tocilizumab in ALS Subjects Start of enrollment: 2015 Nov 01
Publications & Presentations
PubMed
- 36 citationsReducing sample size requirements for future ALS clinical trials with a dedicated electrical impedance myography system.Jeremy M. Shefner, Seward B. Rutkove, James B. Caress, Michael Benatar, William S. David
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2018-09-28 - 118 citationsElectrical impedance myography as a biomarker to assess ALS progression.Seward B. Rutkove, James B. Caress, Michael S. Cartwright, Ted M. Burns, Judy Warder
Amyotrophic Lateral Sclerosis. 2012-08-16 - 110 citationsMultipoint incremental motor unit number estimation as an outcome measure in ALSJeremy M. Shefner, Mary Lou Watson, L. Simionescu, James B. Caress, Ted M. Burns
Neurology. 2011-07-19
Press Mentions
- Dosing Begins in Phase 2a Study of ALZT-OP1a for Mild-to-Moderate ALSSeptember 16th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: